Intelligence Β· Drug directory
EMA-Approved Drugs Directory
European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
Quick answer
EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
-
riociguat
ADEMPAS Bayer Australia Ltd
C02KX05 -
risperidone
APO-RISPERIDONE Servier Laboratories (Aust.) Pty.
N05AX08 -
ritonavir
NORVIR AbbVie
J05AE03 -
rivaroxaban
APO-RIVAROXABAN Alphapharm Pty Ltd
B01AF01 -
rivastigmine
EXELON Novartis Pharmaceuticals
N06DA03 -
roflumilast
DAXAS Arcutis Biotherapeutics
R03DX07 -
salmeterol
SEFFALAIR SPIROMAX Teva Pharma GmbH
R03AK06 -
sapropterin
KUVAN BioMarin Pharmaceutical Australia Pty Ltd
A16AX07 -
saxagliptin
ONGLYZA AstraZeneca
A10BD21 -
sebetralstat
EKTERLY Kalvista Pharmaceuticals (Ireland) Limited
B06AC08 -
selinexor
XPOVIO Shanghai Antengene Corporation Limited
L01XX66 -
sepiapterin
SEPHIENCE PTC THERAPEUTICS, INC.
A16AX28 -
setmelanotide
IMCIVREE Rhythm Pharmaceuticals Netherlands B.V.
A08AA -
sevelamer carbonate
RENVELA Amneal Pharma Europe Ltd
V03AE02 -
sildenafil
NOUMED SILDENAFIL Alphapharm Pty Ltd
G04BE03 -
silodosin
UROREC Lacuna Pharma Pty Ltd
G04CA04 -
sirolimus
RAPAMUNE Pfizer Australia Pty Ltd
L04AH01 -
sodium oxybate
XYREM Amneal Pharma Europe Ltd
N07XX04 -
sodium phenylbutyrate
PHEBURANE Lacuna Pharma Pty Ltd
A16AX03 -
sodium thiosulfate
PEDMARQSI FENNEC PHARMACEUTICALS INC.
-
sofosbuvir
EPCLUSA Teva Pharma GmbH
J05AX15 -
sparsentan
FILSPARI Travere Therapeutics
C09XX01 -
spironolactone
ALDACTONE Pfizer Australia Pty Ltd
C03DA01 -
tacrolimus
ADVAGRAF XL Alphapharm Pty Ltd
D11AH01
Frequently asked questions
How many ema approved drugs are listed?
931 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.